KEVIN BEULER: Open Payments
NPI 1144704057 · CORFU, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$712 in 37 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $40 · 2025 $712
Food & beverage: $712
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $166 |
| AstraZeneca Pharmaceuticals LP | 6 | $104 |
| Exact Sciences Corporation | 4 | $71 |
| GlaxoSmithKline, LLC. | 4 | $71 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| Abbott Laboratories | 3 | $66 |
| Corium, LLC | 4 | $35 |
| Axsome Therapeutics, Inc. | 1 | $34 |
| Indivior Inc. | 1 | $30 |
| Phathom Pharmaceuticals, Inc. | 1 | $28 |
Products named: Ozempic, Cologuard Collection Kit, XIFAXAN, FREESTYLE LIBRE 3, AIRSUPRA, BREZTRI, SHINGRIX, Azstarys.
Industry payments across NY — which companies pay providers there.
